New York-based biopharmaceutical company Emisphere Technologies has hired former Ernst and Young derivatives specialist Elliot Maza as chief financial officer. He will be responsible for leading the company's effort in financial operations, planning and corporate governance.At Ernst and Young, Maza served as a partner in transaction advisory services. His main responsibilities included advising clients on the implications of capital markets transactions on tax and financial statements, including asset securitization and derivatives. Before that he was vice-president of structured finance at Goldman Sachs.
Maza will have ultimate responsibility for the finance and accounting departments and report to Michael Goldberg, Emisphere’s chief executive.
Sign up for Risk.net email alerts
UK, 12th - 6th Dec 2013
UK, 25th - 26th Feb 2014
USA, 27th - 28th Feb 2014
There are no comments submitted yet. Do you have an interesting opinion? Then be the first to post a comment.
Updating your subscription status
Risk iPad and iPhone Apps